Marinus Pharmaceuticals Inc
(NASDAQ : MRNS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
2.43%18.152.0%$258.39m
SHPGShire PLC Sponsored ADR
-1.90%175.590.4%$221.25m
JAZZJazz Pharmaceuticals Plc
-0.60%142.802.2%$105.01m
PRGOPerrigo Co. Plc
-0.38%63.276.8%$104.98m
ENDPEndo International Plc
-0.31%12.698.9%$64.86m
GWPHGW Pharmaceuticals PLC Sponsored ADR
1.50%132.306.3%$64.59m
MNKMallinckrodt Plc
-1.85%30.8521.1%$58.56m
SAGESAGE Therapeutics, Inc.
2.08%114.219.6%$57.88m
HZNPHorizon Pharma plc
2.87%21.867.4%$53.25m
ICPTIntercept Pharmaceuticals, Inc.
1.80%102.7018.7%$51.93m
UTHRUnited Therapeutics Corporation
4.45%121.4914.4%$49.60m
CTLTCatalent Inc
0.87%39.392.4%$40.94m
PTLAPortola Pharmaceuticals, Inc.
-0.99%20.007.7%$34.00m
ICLRICON Plc
-1.58%132.874.1%$33.59m
AERIAerie Pharmaceuticals, Inc.
0.33%42.876.9%$29.36m

Company Profile

Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the identification and development of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded by Geoffrey E. Chaiken, Harry H. Penner Jr., Vincent A. Pieribone and Kenneth R. Shaw on August 14, 2003 and is headquartered in Radnor, PA.